SPR Therapeutics has received Food and Drug Administration ( FDA ) clearance for an expansion of its wearable Sprint Peripheral Nerve Stimulation pain management device . The Ohio - based company said the device would now be available as single or dual lead , able to use rechargeable batteries , and be Bluetooth - enabled . The company’s primary competition in the wearable pain management device space is Neurometrix’s Quell, which is worn above the skin. The device is a percutaneous electrical nerve stimulator , and involves a wire being passed through a patient ’s skin to target nerve fibres and relieve pain . It can be used for up to 60 minutes . SPR said the placement was reversible and would be ideal for shorter outpatient procedures .
SPR Therapeutics has received Food and Drug Administration ( FDA ) clearance for an expansion of its wearable Sprint Peripheral Nerve Stimulation pain management device . The Ohio - based company said the device would now be available as single or dual lead , able to use rechargeable batteries , and be Bluetooth - enabled . The device is a percutaneous electrical nerve stimulator , and involves a wire being passed through a patient ’s skin to target nerve fibres and relieve pain . It can be used for up to 60 minutes . SPR said the placement was reversible and would be ideal for shorter outpatient procedures .